GlobeNewswire
-
Cue Biopharma Names Shao-Lee Lin M.D., Ph.D., CEO, President and Board Director to Lead Continued Growth and Transformation into a Clinical-Stage Company
30/04/2026 -
Aligos Therapeutics to Announce 1st Quarter 2026 Financial Results on May 7, 2026
30/04/2026 -
Nyxoah to Participate in the Bank of America 2026 Healthcare Conference
30/04/2026 -
Nyxoah Participera à la Conférence Bank of America 2026 Healthcare
30/04/2026 -
Trevi Therapeutics Announces Oral Presentation and Multiple Posters Accepted at the American Thoracic Society (ATS) 2026 International Conference
30/04/2026 -
Elutia to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026
30/04/2026 -
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
30/04/2026 -
Senseonics Announces Commencement of $80 Million Public Offering of Common Stock and Pre-Funded Warrants
30/04/2026 -
The Ensign Group Acquires Real Estate and Expands Operations in Texas
30/04/2026 -
The Ensign Group Purchases Facilities in Wisconsin
30/04/2026 -
Syndax Reports First Quarter 2026 Financial Results and Provides Business Update
30/04/2026 -
OrthoPediatrics Expands Specialty Bracing Portfolio with TRAXIO Halo Gravity Traction System
30/04/2026 -
Ardelyx Reports First Quarter 2026 Financial Results and Provides Business Update
30/04/2026 -
Xenon to Report Q1 2026 Financial Results on May 7, 2026
30/04/2026 -
Rakovina Therapeutics Inc. Announces 2025 Financial Results and Provides Corporate Update
30/04/2026 -
TELA Bio Announces Strategic Board Refreshment with Four Highly Experienced Commerical Leaders to Accelerate Growth and Drive Path to Profitability; The Company Also Reports Preliminary First Quarter 2026 Revenues
30/04/2026 -
Emergent BioSolutions Reports First Quarter 2026 Financial Results
30/04/2026 -
DBV Technologies Reports First Quarter 2026 Financial Results
30/04/2026 -
DBV Technologies publie ses résultats financiers du 1er trimestre 2026
30/04/2026
Pages